5 Most Promising Cancer Stocks According to Analysts

Page 1 of 5

In this piece, we will take a look at the five most promising cancer stocks according to analysts. If you want to learn all about the cancer treatment industry, then check out 12 Most Promising Cancer Stocks According to Analysts.

5. Theseus Pharmaceuticals, Inc. (NASDAQ:THRX)

Latest Analyst Share Price Upside: 82.13%

Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) is developing treatments for stomal tumors and lung cancer. The firm’s shares gained more than 50% in November 2023 after it announced restructuring plans that impressed investors.

By the end of this year’s third quarter, nine out of the 910 hedge funds surveyed by Insider Monkey had bought and owned Theseus Pharmaceuticals, Inc. (NASDAQ:THRX)’s shares. Samuel Isaly’s OrbiMed Advisors was the biggest investor through its $47.6 million stake.

Follow Theseus Pharmaceuticals Inc.

Page 1 of 5